CPRIT Provides $10.8M Grant to Advance Breakthrough Oncolytic Virus Therapy for Glioblastoma
Overview The Cancer Prevention & Research Institute of Texas (CPRIT) provided $10.8 million grant to advance the development and commercialization of an innovative oncolytic adenovirus therapy for glioblastoma (GB), one…